R. Hegedus

Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study

J. Crues, M. Weisman, D. Furst, 2007, Annals of the rheumatic diseases.

P087 - SONIC: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to immunomodulators and biologic therapy

P. Rutgeerts, G. D'Haens, A. Kornbluth, 2008 .

Onset of symptom relief with rabeprazole: a community‐based, open‐label assessment of patients with erosive oesophagitis

R. Hegedus, M. Robinson, L. Jokubaitis, 2002, Alimentary pharmacology & therapeutics.

IgG and IgM anticardiolipin antibodies following treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.

E. S. St. Clair, J. Smolen, S. Visvanathan, 2006, Arthritis and rheumatism.

A multicenter retrospective experience of infliximab in Crohn's disease patients: infusion reaction rates and treatment persistency.

A. Keshavarzian, L. Mayer, F. Cominelli, 2007, Gastroenterology & hepatology.

T1142 Infliximab Treatment for Ulcerative Colitis: Clinical Response, Clinical Remission, & Mucosal Healing in Patients with Moderate or Severe Disease in the Active Ulcerative Colitis Trials (ACT1 & ACT2)

P. Rutgeerts, W. Sandborn, O. Dabbous, 2008 .

A multicenter, randomized, open study to evaluate the impact of an electronic data capture system on the care of patients with rheumatoid arthritis*

S. Kasle, D. Yocum, N. Yeilding, 2007, Current medical research and opinion.